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Abstract
Stimuli-responsive smart-biomaterial-based approaches have been identified as a promising tool for nerve
regeneration and neural tissue engineering. Understanding the stimuli-responsive behavior of the smart
materials, along with the fundamentals of cellular interactions, is the key to future strategies for neural tissue
engineering. Advances in the development and application of smart biomaterials and 3-D scaffold fabrication
techniques as well as cellular reprogramming and transdifferentiation technologies make it possible to
combine stem cells, cellular engineering, drug/gene delivery systems, nanotechnology and biomaterial-based
therapies to develop experimental and clinical strategies for neural tissue engineering. The application of
smart biomaterials in these technologies is likely to contribute synergistically to the improvement of
therapeutic strategies for clinical translation. This review chapter focuses on the use of strategies combining
stimuli-responsive smart biomaterials with other technologies in neural tissue engineering. A specific
emphasis on temperature, pH, enzyme, photo-triggered, self-assembling and electrical stimuli-sensitive mono
or multi-responsive smart biomaterials in neural tissue engineering is presented. A summary of the clinical
potential and applications of smart materials in neural tissue engineering is also presented at the end to
illustrate how smart materials can be effective in combination with these technologies to enhance neural
regeneration.
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14.1   Introduction
physical damage to the central nervous system (CnS) and the presence of 
chronic neurodegenerative diseases, such as parkinson’s and alzheimer’s, 
causing loss of neuronal cells, axons, and associated glial support, are the 
main reasons for the disruption of brain architecture.1,2 the self-repairing 
capacity of the CnS and replacement potential of lost neurons are limited 
due to injury or disease-associated inflammatory responses causing microg-
lial infiltration, astrocyte proliferation and glial scarring, as well as reduced 
neuronal proliferation.3 a combination of these effects suppresses the repar-
ative and proliferative processes in the CnS. therefore, the presence of cues 
and signals for cell migration, axonal guidance and synapse formation as 
well as the neuronal phenotypes, are needed in order to facilitate the par-
ticipation of intrinsically derived neurons or implanted stem-cell-based 
therapies in adult CnS repair.3 in addition, the transport of applied drugs 
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383Smart Materials for Nerve Regeneration and Neural Tissue Engineering
or neurotrophic factors across the blood–brain barrier (BBB) to target brain 
sites for long-term activity is also another fundamental challenge.4 On the 
other hand, compared to the adult CnS possessing a growth inhibitory envi-
ronment, the presence of Schwann cells, facilitating axonal regrowth upon 
damage, provides a greater repairing capacity for peripheral nervous system 
(pnS) neurons.5,6 the myelin and axon debris formed after traumatic injury 
to peripheral nerves are removed by macrophages and monocytes migrating 
into the nerve stumps. at the same time, Schwann cells proliferate to secrete 
neurotrophic factors and extracellular matrix (eCM) molecules. these 
synergistic actions facilitate axon regeneration to achieve functional recovery. 
despite the self-healing capacity, peripheral nerve repair with poor functional 
recovery is achieved, particularly for large peripheral nerve gaps.6 in order 
to address these issues in the CnS and pnS, various approaches, including 
delivery of drugs, neurotrophic factors and stem cell therapies, allowing 
reprogramming and transdifferentiation, based on different biomaterials 
and 3d scaffold fabrication techniques, have been applied in neural tissue 
engineering and nerve regeneration.2,7–11
Biomaterials fabricated from natural and synthetic sources, possessing 
many features (including biocompatibility, biodegradability, biological activ-
ity, mechanical properties, surface chemistry, and growth factor binding 
capabilities) have been used for the fabrication of 3d scaffolds providing an 
available eCM microenvironment that enables cell (native or transplanted) 
growth and differentiation along with an efficient drug/neurotrophic factor 
delivery platform.12–33 among these materials, stimuli-responsive smart bio-
materials, that are capable of showing large conformation- or property-based 
responses to small physical or chemical changes, have been addressed as 
promising candidates providing 3d scaffolds and drug/neurotrophic factor 
delivery platforms for neural tissue engineering and nerve regeneration.
this review chapter overviews recent advances in the use of stimuli-respon-
sive smart-biomaterial-based strategies to overcome the key hurdles of neural 
tissue engineering and nerve regeneration. the chapter specifically focuses 
on temperature-, ph-, enzyme- and photo-triggered self-assembling mono- or 
multi-responsive biomaterial-based 3d scaffolds and delivery platforms for 
drug/neurotrophic factors and stem cell therapies used in neural tissue engi-
neering and nerve regeneration. a separate section emphasizing electrically 
conductive materials and graphene is also included. in the last part, surface 
functionalized delivery systems for traversing the BBB and gene delivery 
systems and strategies are mentioned briefly. the chapter ends with a discus-
sion about the clinical potential and applications of smart materials in neural 
tissue engineering followed by concluding remarks and future perspectives.
14.2   Stimuli-Responsive Biomaterials for Neural 
Tissue Engineering and Nerve Regeneration
different types of stimuli-responsive smart biomaterials have been used 
for neural tissue engineering and nerve regeneration purposes as promis-
ing candidates providing 3d scaffolds and drug/neurotrophic factor delivery 
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platforms. they respond sensitively to physical or chemical changes, such as 
temperature, ph, enzymatic reactions, light and electrical stimuli by show-
ing relatively large conformation or property changes. the types of materials, 
their stimuli responses and descriptions are discussed below and outlined in 
table 14.1.
14.2.1   Temperature-Responsive Biomaterials
temperature-responsive materials have been mostly used to develop inject-
able in situ forming hydrogel scaffolds, allowing precise and controlled local-
ization at the desired site in the liquid phase, for neural tissue engineering. 
a commonly used thermoresponsive polymer, poly(N-isopropylacrylamide) 
(poly(nipaaM)), is capable of changing conformation from a coil to a globule 
at temperatures higher than the lower critical solution temperature (lCSt: 
32 °C). at these temperatures, the water molecules attached to the isopro-
pyl side groups are released, leading to poly(nipaaM) phase separation and 
enhancement in hydrophobic interactions.89–92 however, the large shrinkage 
of poly(nipaaM) upon a temperature change reduces the cell encapsulation 
and protein delivery efficacy of this polymer. in order to prevent the shrink-
ing problem and enhance cell entrapment and compatibility, poly(nipaaM) 
chains have been further modified by hydrophilic blocks including acrylic 
acid or polyethylene glycol (peg).93,94 For instance, pnipaam modified with 
peg was used as a biocompatible, injectable scaffold for the treatment of 
spinal cord injuries.34 the temperature-responsive injectable pnipaam–
peg-based scaffold allowed bone marrow stromal cell attachment and a 
sustained release of neurotrophic factors along with providing mechanical 
support matching the native neuronal tissue.34 Besides the large shrinkage, 
the lack of biodegradation of poly(nipaaM) is also another problem for tis-
sue engineering applications. in order to address this issue, poly(nipaaM) 
has been introduced to the backbone of biodegradable polymers such as chi-
tosan, gelatin, hyaluronic acid and dextran.35,36,95,96
Biodegradable and biocompatible gelatin with thermoreversible proper-
ties and facile modification at the amino acid level is considered as another 
potential biopolymer. Below 25 °C, triple helix formation occurs, causing the 
solidification of aqueous gelatin and creation of a rigid 3d network, while 
above 30 °C, the reverse is exhibited through a conformation change from a 
helix to a flexible coil.35,36 Since this thermal behavior of gelatin is opposite to 
what is usually required in biomedical applications, a combination of gelatin 
with other polymers is also needed to show thermal gelation close to body 
temperature. For this purpose, poly(N-isopropylacrylamide)-grafted gelatin 
(pnipaM–gelatin) was also examined as a temperature-responsive biode-
gradable in situ formed injectable 3d scaffold.36
amphiphilic block copolymers, containing both hydrophobic and hydro-
philic blocks, along with temperature-responsive properties (such as peO–
ppO–peO (pluronicF127), plga–peg–plga, peg–plla–peg, pCl–peg–pCl 
and peg–pCl–peg) are other potential scaffold materials for neural tissue 
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Table 14.1   types of biomaterials, their stimuli responses and descriptions.
Material
Stimuli 
response application/description Outcome references
pnipaam–peg thermo-
responsive
injectable scaffold for bone marrow 
stromal cells’ attachment and a 
sustained release of neurotrophic 
factors
provided mechanical support matching the 
native neuronal tissue and enhanced cell 
encapsulation
34
pnipaM–gelatin thermo-
responsive
In situ formed injectable 3d scaffold 
for cells
provided enhanced biodegradability to pnipaM 35 and 36
peg-(poly-l-ala-
nine)
thermo-
responsive
3d hybrid scaffolds comprising neuro-
nal differentiated MSCs and growth 
factor releasing microspheres
exhibited mechanical properties similar to 
brain tissue, capable of baring the micro-
spheres and MSCs throughout 3d culture
37
Methylcellulose- 
tethered 
laminin-1
thermo-
responsive
Bioactive scaffold as a delivery vehicle 
for CnS and neural cell transplan-
tation laminin-1 to methylcellulose 
through Schiff base reaction
enhanced low protein adsorption and cell  
adhesion of methylcellulose for neural  
tissue engineering applications
38
Chitosan/glycero-
phosphate 
salt hydrogel 
with pdla
thermo-
responsive
3d chitosan/glycerophosphate salt 
hydrogels, containing immobilized 
poly-d-lysine onto chitosan via  
azidoaniline photocoupling
Certain peptide polylysine concentrations 
improved neuronal adhesion and neurite  
outgrowth in 3d gel geometry
39
Xyloglucan 
hydrogels
thermo-
responsive
Xyloglucan hydrogel scaffolds  
functionalized through the  
immobilization and grafting of 
poly-d-lysine
promoted neuron adhesion and neurite  
outgrowth for the spinal cord. native spinal 
cord mimicking mechanical properties, 
allowing migration of neural stem cells, 
direction of neurite growth and infiltration 
of axons, astrocytes and neurites with higher 
concentrations
5,40–42
pdeaeM–
pluronicF127–
pdeaeM
ph and  
temperature 
responsive
hydrogels composed of temperature- 
responsive pluronic F127 and ph- 
responsive cationic pdeaeM
potential as 3d scaffolds for cellular growth and 
depot for drug/neurotrophic factor delivery 
for neural tissue engineering applications
43–59
(continued)
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iKVaV, ldlK12, 
rada16 
peptides
Self-assembly nanofibrillar gels and scaffolds  
developed through spontaneous 
self-assembly of ionic  
self-complementary peptides
Mimicking eCM. enhanced neural cell  
attachment, proliferation, migration and  
differentiation. induced neurite outgrowth 
and synapse formation
60–71
photocrosslink-
able meth-
acrylamide 
chitosan
photorespon-
sive
photocrosslinkable methacrylamide 
chitosan-based porous 3d scaffold
provide differentiation of neural stem/ 
progenitor cells into neurons, astrocytes  
and oligodendrocytes
72
amino ethyl 
methacrylate – 
Chitosan
photorespon-
sive
amino-ethyl methacrylate derivatized, 
degradable, photocrosslinkable  
chitosan 3d scaffolds
the scaffolds showed toxic effect against MSCs 
while enhancing the nSC differentiation into 
neurons and astrocytes
73
hrp catalyzed 
gelatin- 
hydroxyphen-
ylpropionic 
acid hydrogels
enzyme 
responsive
provided the stiffness-dependent  
differentiation of human  
mesenchymal stem cells (hMCSs) 
on hrp catalyzed gelatin-
hydroxyphenyl propionic acid 
hydrogels
the hydrogel stiffness stimulated neurogenesis 
and myogenesis of hMSCs along with high 
migration and proliferation rate. hMSCs 
encapsulated in soft hydrogels provided 
enhanced proliferation rate and neuronal 
protein marker expression compared to the 
hydrogels with higher stiffness
74 and 75
hrp catalyzed 
gelatin-hy-
droxyphenyl-
propionic acid 
hydrogels
enzyme 
responsive
provided the stiffness-dependent  
differentiation of adult neural stem 
cells (anSCs) on hrp catalyzed  
gelatin-hydroxyphenylpropionic 
acid hydrogels
Observed self-renewal and differentiation of 
anSCs into central nervous system cell types. 
Stiffer hydrogels enhanced neuronal lineage 
differentiation of anSCs, improved cell  
adhesion, oxidative stress resistance and  
cell proliferation and migration
76
Conductive 
polymers
electrical 
stimuli 
responsive
ngF-doped ppy films,77 ppy–plga,78 
ppy–pdlla79 and plla–pani80 
scaffolds
promoted survival, neurite outgrowth and  
density of viable neurons resulting in neural 
network formation
77–80
Table 14.1  (continued) 
Material
Stimuli 
response application/description Outcome references
D
o
w
n
l
o
a
d
e
d
 
b
y
 
I
o
w
a
 
S
t
a
t
e
 
U
n
i
v
e
r
s
i
t
y
 
o
n
 
0
7
/
1
2
/
2
0
1
7
 
1
6
:
4
4
:
0
7
.
 
P
u
b
l
i
s
h
e
d
 
o
n
 
0
3
 
M
a
y
 
2
0
1
7
 
o
n
 
h
t
t
p
:
/
/
p
u
b
s
.
r
s
c
.
o
r
g
 
|
 
d
o
i
:
1
0
.
1
0
3
9
/
9
7
8
1
7
8
8
0
1
0
5
4
2
-
0
0
3
8
2
View Online
387
Sm
art M
aterials for N
erve Regeneration and N
eural Tissue Engineering
Collagen coated 
ppy scaffold
electrical 
stimuli 
responsive
inkjet-printed collagen-coated  
conductive ppy scaffold with  
guidance tracks
enhanced guided neurite outgrowth 81
gelatin- 
graft-polyani-
line
electrical 
stimuli 
responsive
In situ forming biodegradable  
electroactive gelatin-graft-polyaniline 
hydrogels by crosslinking with  
genipin at body temperature
enhanced MSC adhesion and proliferation upon 
electrical stimuli
82
ppy/pMaS electrical 
stimuli 
responsive
ppy/pMaS composite films enhanced the ngF triggered neural differentia-
tion of cells
83
Fibrillar  
collagen- 
coated ppy
electrical 
stimuli 
responsive
Fibrillar collagen-coated ppy scaffolds enhanced neural differentiation of rat  
pheochromocytoma nerve cells when  
electrical stimulus was applied
84
graphene foam electrical 
stimuli 
responsive
3d porous graphene foam with  
electrically conductive properties
Supported neural stem cell (nSC) growth with 
active proliferation state and enhanced nSC 
differentiation towards astrocytes and  
neurons through efficient electrical stimulation
85
graphene electrical 
stimuli 
responsive
graphene-coated substrate extremely low frequency electromagnetic fields 
enhanced neuronal differentiation of bone 
marrow-derived hMSCs
86
graphene oxide electrical 
stimuli 
responsive
3d conductive nanofibers achieved 
through the controlled assembly of 
graphene oxide sheets into the elec-
trospun polymer nanofiber surface
enhanced electrical stimulation, accelerated  
cellular growth and primary motor neurons
87
graphene oxide 
and gold 
nanoparticles
electrical 
stimuli 
responsive
gold nanoparticles containing 3d 
graphene oxide to monitor and 
detect the differentiation potential 
of neural stem cells (nSCs) using 
surface-enhanced raman  
spectroscopy (SerS)
promoted SerS signals of graphene oxide and 
gold nanoparticles for undifferentiated nSCs. 
promising in situ monitoring tool for stem 
cell differentiation
88
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engineering and cell delivery.97–99 in these stimuli-responsive copolymer 
designs, the amphiphilic polymer chains self-assemble into micellar struc-
tures at low temperatures, whereas more hydrophobic segments leading 
to increased hydrophobicity and micellar aggregation form hydrogels at 
lCSt.100,101 For example, 3d hybrid scaffolds based on a temperature-respon-
sive poly(ethylene glycol)–poly(l-alanine) (peg–l-pa) polymer comprising 
neuronal differentiated tonsil-derived mesenchymal stem cells (tMSCs) and 
microspheres releasing growth factors were developed previously (Figure 
14.1(a)).37 the in situ formed gel mimicked the mechanical properties of brain 
tissue and showed robust characteristics enabling the presence of micro-
spheres in the structure during 3d tMSCs culturing (Figure 14.1(B) and (C)).37
these synthetic block copolymers can also be used in combination with 
natural polymers to enhance their biocompatibility, biodegradability and 
mechanical properties. in a study, thermoresponsive and biodegradable 
scaffolds composed of thermoresponsive poly(N-isopropylacrylamide) (pni-
paam), hydrolytically degradable and hydrophobic poly(l-lactic acid) (plla) 
and enzymatically degradable and hydrophilic natural dextran blocks were 
designed for nerve growth factor controlled release.102
Many natural temperature-responsive materials, such as cellulose deriva-
tives, chitosan, gelatin, dextran etc., have been used alone or in combination 
with synthetic polymers for the fabrication of thermoresponsive scaffolds.103 
among those, a cellulose derivative, methylcellulose (MC), shows thermore-
sponsive gelation between 60 and 80 °C and liquification upon cooling.104,105 
although the lCSt range of MC is not suitable to show a thermoresponsive 
effect by direct body injection, particularly for neural tissue engineering 
applications, adjusting the lCSt range is possible through grafting MC with 
other thermoresponsive materials (i.e. synthetic N-isopropylacrylamide) by 
changing their relative ratios as mentioned in previous work.106 however, 
the application of methylcellulose for neural tissue engineering is limited 
by the low protein adsorption and cell adhesion properties. this issue was 
addressed through a bioactive scaffold, which was developed as a delivery 
vehicle for neural cell transplantation strategies in injured CnS tissue. in this 
strategy, laminin-1 was tethered to thermoresponsive MC through a Schiff 
base reaction occurring between the primary amine groups of laminin and 
the carbonyl groups of the oxidized MC chain.38
another natural material, chitosan, obtained by deacetylation of chitin, 
mostly forms thermosensitive hydrogels with polyol salts.107 a chitosan/glycer-
ophosphate salt hydrogel was first developed for potential neural tissue engi-
neering applications.108 Following that, 3d chitosan/glycerophosphate salt 
hydrogels with thermoresponsive properties, containing immobilized poly-
d-lysine, were fabricated via azidoaniline photocoupling, enhancing neurite 
outgrowth for neural tissue engineering.39 it was noted that certain peptide 
polylysine concentrations improved neuronal adhesion and neurite outgrowth 
in 3d gel architectures mimicking the extracellular matrix. One problem with 
chitosan is the solubility and gelation issue at physiological ph, which can 
also be adjusted by grafting some hydrophilic moieties such as peg.103,109
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Xyloglucan, a biocompatible polysaccharide, shows thermoresponsive char-
acteristics upon removal of more than 35% of galactose residues.110 although 
xyloglucan gels were previously demonstrated as potential drug carriers for 
different applications,107 their application in neural tissue engineering was 
rare due to the limited rheological and morphological characteristics. pre-
vious work examined the gelation properties and morphology of xyloglucan 
Figure 14.1   (a) 3d peg–l-pa thermogel cell culture matrix incorporated with algi-
nate microspheres containing neuronal growth factor. tMSCs’ neu-
ronal differentiation was manipulated by the controlled release of 
neuronal growth factors, BdnF and ngF. (B) SeM images of BdnF-
loaded (BdnF–MS) and ngF-loaded (ngF–MS) alginate microspheres 
and storage (g′) and loss (g″) modulus of peg–l-pa aqueous polymer 
solutions. (C) Cell images of tMSC after 3d culturing 0, 14, and 28 d in 
the absence of growth factor (p), presence of growth factor (gp), and 
3d cell culture (Mp) systems.37 (reproduced with permission from 
patel et al., Adv. Healthcare Mater., 4, 1565–1574, 2015. Copyright 2015: 
John Wiley and Sons.)
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hydrogels at physiological conditions,111 which led to further development 
in thermoresponsive xyloglucan hydrogel scaffold functionalization through 
the immobilization and grafting of poly-d-lysine to promote neuron adhe-
sion and neurite outgrowth for the spinal cord. it was shown that mechanical 
properties mimicking the native spinal cord and allowing neural stem cell 
migration, directed neurite growth and infiltration of axons, astrocytes and 
neurites with higher concentrations, were possible with these gels.5,40–42
14.2.2   pH-Responsive Biomaterials
the copolymerization of poly(nipaaM) or block copolymer hydrogels 
with ph-sensitive acrylates, such as 2-(dimethylamino) ethyl methacry-
late (dMaeMa) or 2-(diethylaminoethyl) methyl methacrylate (deaeMa), 
enables both temperature- and ph-responsiveness. these dual-responsive 
polymers provided extended protein release in previous work.112,113 Simi-
larly, in our group, ph- and temperature-responsive, amphiphilic and cat-
ionic pentablock copolymers, composed of temperature-responsive pluronic 
F127 (poly(ethyleneoxide)-block-poly(propyleneoxide)-block-poly(ethylene-
oxide) (peO-b-ppO-b-peO)) mid-block and ph-responsive cationic pdeaeM 
(poly(2-diethylaminoethyl methacrylate)) end-blocks, were synthesized via 
atom transfer radical polymerization (atrp). these polymers were used 
for both pdna and sirna delivery, as well as a vaccine carrier, due to their 
several advantages in eliminating the intra/extra cellular barriers over their 
counterparts (Figure 14.2). the central triblock, pluronic F127, facilitates 
cellular entry via thermoresponsive micellization while the ph-responsive 
cationic end blocks, pdeaeM, enable complexation with negatively charged 
nucleic acids and endosomal escape.43–47,50,51,54–59 the hydrophobic poly(pro-
pyleneoxide) (ppO) block in the middle of pluronic F127 with a lCSt of ∼8 °C 
is responsible for the thermoreversible micellization. in addition, the hydro-
phobic nature of ppO chains enhances the particle–cell interactions, facili-
tates the particle incorporation into cell membranes and promotes cellular 
entry of delivery systems without altering cell membrane integrity.48,49,53 the 
cationic end blocks, poly(diethylaminoethyl methacrylate) (pdeaeM) with a 
pKa of ∼7.3, provide electrostatic complexation with negatively charged pdna 
or sirna. Moreover, the ph buffering capacity of these segments through the 
presence of protonatable tertiary amine groups, facilitates the endosomal 
escape of the delivery system via the proton sponge mechanism at the low 
ph of the endosome.45,48,57 despite the advantages, ph-responsive hydrogels 
are not generally considered preferred cell carriers due to the in vivo biocom-
patibility and stability concerns. however, adjusting the balance between the 
cationic and non-ionic blocks makes it possible to manipulate the cytotox-
icity of these copolymers.47 in addition, the temperature- and ph-responsive 
gelation of these polymers was also reported as addressing the potential for 
3d scaffolds, providing available space for cellular growth as well as acting 
like a depot for drug/neurotrophic factor delivery for neural tissue engineer-
ing applications.
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14.2.3   Self-Assembling Biomaterials
responsive short peptides with self-assembly properties have shown prom-
ise in the development of 3d scaffolds for tissue engineering.114,115 these 
peptides form higher order self-assembled structures through weak and 
non-covalent interactions. the adjustment of the amino acid sequence 
controls the formation of various secondary structures (such as β-sheets, 
β-hairpins and α-helices) and their bonding interactions (such as hydrogen 
bonding, ionic, electrostatic, hydrophobic and van der Waals), which in 
turn affect the spontaneous formation of nanofibers, 3d hydrogels and scaf-
folds.116,117 these peptides have the advantage of possessing a shear thin-
ning property and they form scaffolds under physiological conditions giving 
the ability of post-stress in situ self-assembly and mechanical recovery. 
Figure 14.2   (a) temperature- and ph-responsive self-assembly and micelle forma-
tion of pentablock copolymer molecules. (B) polyplex formation with 
dna through electrostatic attraction and shielding of excess positive 
charges via pluronic self-assembly. (C) Self-assembly of polyplexes 
with paclitaxel (ptX) encapsulated pluronic to create a carrier loaded 
by both dna and ptX for dual delivery.56 reproduced from Interna-
tional Journal of Pharmaceuticals, 427(1), zhang, B., Jia, F., Fleming, M. 
Q., Mallapragada, S. K., injectable self-assembled block copolymers 
for sustained gene and drug co-delivery: an in vitro study, 88–96, Copy-
right (2012) with permission from elsevier.
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Various self-assembling peptides have successfully been used for neural cell 
culture. For example, nanofibrillar gels and scaffolds have been developed 
through spontaneous self-assembly of ionic self-complementary peptides 
while self-assembling peptide amphiphiles with biological signaling prop-
erties, such as iKVaV (isoleucine–lysine–valine–alanine–valine), have been 
used for 3d cell culture.64,67,70,71 iKVaV, a laminin epitope, has been shown 
to enhance the differentiation of neural progenitor cells into neurons.69 
Similarly, the binding of ldlK12 self-assembling peptide to murine neural 
stem cell (nSC) derived neural precursor cells (npCs) enhanced the viability 
and differentiation.62 On the other hand, the spontaneous self-assembly of 
rada16-like peptides (rada16-i and rada16-ii) into antiparallel β-sheets 
under physiological conditions resulted in the formation of nano and micro-
fibers. these fiber structures mimic the eCM structure, induce neurite out-
growth and synapse formation in pC12 cells65,66 and facilitate neural stem 
cell proliferation and differentiation.61,68 Moreover, rada16-i has also been 
reported to induce osteoblast proliferation, differentiation, and migration. 
rada16-i, possessing 99% water content, can resolve into natural amino 
acids and further be custom designed for the incorporation of functional 
segments (such as BMhp1 and 2). Because of these features, this peptide 
has been addressed as a promising self-assembling peptide for neural 
tissue engineering applications (Figure 14.3).60,63 Considering their proper-
ties, self-assembling peptides are promising candidates for neural tissue 
engineering as responsive polymers.
14.2.4   Photo-Responsive Biomaterials
photopolymerization enables the in situ formation of hydrogel scaffolds at 
physiological ph and temperature. hydrogel scaffolds are mainly formed 
upon visible light/UV exposure through a reaction between free radicals, pro-
duced by decomposition of the photoinitiator, and polymerizable acrylate 
or methacrylate groups. photo stimuli can be used for the encapsulation of 
viable cells without damaging the cell structure and by allowing favorable 
gelation conditions.118 photocrosslinkable polymers, such as poly(ethylene 
glycol)-diacrylate (pegda), poly(ethylene glycol)-dimethacrylate (pegdMa), 
poly(propylene fumarate) (ppF) and oligo(poly(ethylene glyco) fumarate) 
(OpF) have been investigated for tissue engineering applications.119–123 For 
instance, as an alternative to traditional photocuring methods, a 3d hydrogel 
scaffold based on photocurable poly(ethylene glycol) resin using novel cus-
tom built laser-based microstereolithography has recently been developed 
for the manufacture of a nerve growth conduit aimed at large peripheral 
nerve gaps. this method was proposed as a new platform for rapid microfab-
rication and the development of advanced designs.118
as an alternative to synthetic materials, natural photocrosslinkable hydro-
gel materials such as dextran, alginate, chitosan and hyaluronic acid have 
also been investigated recently along with methacrylation or copolymeriza-
tion.124–127 photocrosslinkable methacrylamide chitosan was used to develop 
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a porous 3d scaffold for differentiation of neural stem/progenitor cells into 
neurons, astrocytes and oligodendrocytes.72 in other work, amino-ethyl meth-
acrylate derivatized, degradable, photocrosslinkable chitosan was developed 
to create 3d scaffolds for MSCs and neural stem cells. the scaffolds showed 
a toxic effect against MSCs while enhancing nSC differentiation into neurons 
and astrocytes.73 although the overall scaffolding performance of photo- 
responsive materials for stem-cell-based therapies is promising, they are not 
perfectly applicable for clinical purposes.
14.2.5   Enzyme-Responsive Biomaterials
Some materials show endogenous or exogenous enzyme initiated responses 
by forming in situ cross linking and gelation to create scaffolds. this approach 
is advantageous compared to the other scaffolding techniques by avoiding 
side reactions and potential toxicity issues due to the enzyme specificity. 
although different enzymes have been used to provide in situ crosslinking 
or gelation, transglutaminases and horseradish peroxidases are the most 
Figure 14.3   human neural stem cells cultured on BMhp1-Saps self-assembled 
scaffolds. (a) Branched and adhered cells. (B) live/dead cell assays. (C) 
Cell titer assay of cells cultured for seven days over BMhp1-Sap scaf-
folds. (d) nSCs cultured for 14 diV over B24 scaffolds.63 (reproduced 
with permission from gelain et al., ACS Nano, 5, 1845–1859, 2011. 
Copyright 2011: american Chemical Society.)
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utilized enzymes to form scaffolds in tissue engineering applications.128  
a family of thiol enzymes, transglutaminases, catalyzes the reaction between 
the free amine groups of lysine and the g-carboxamide group of glutamine in 
a relatively fast time range (5–20 min) resulting in the formation of a stable 
covalent bond that is highly resistant to proteolysis. although the applica-
tions of transglutaminases, particularly for promoting blood clotting, pre-
venting bleeding and enhancing wound healing, are not common in neural 
regeneration, they have been used in combination with peptides or peg for 
various biomedical applications.129
On the other hand, horseradish peroxidase (hrp), catalyzing the conjuga-
tion of phenol and aniline derivatives in the presence of hydrogen peroxide, 
is the most commonly used peroxidase in hydrogel scaffold formation along 
with natural and synthetic polymers for neural tissue engineering providing 
advantages such as adjustable stiffness, reaction rates, mild cross-linking 
conditions and good biocompatibility.128 in particular, this approach pro-
vides wide control over the scaffold stiffness that affects cell proliferation, 
spreading migration and differentiation.
the stiffness-dependent differentiation of human mesenchymal stem cells 
(hMCSs) on hrp-catalyzed gelatin-hydroxyphenylpropionic acid hydrogels 
was shown previously.74 the stiffness of the hydrogels was controlled within 
the range of 629–12 780 pa by manipulating the hydrogen peroxide concentra-
tion. the neurogenesis and myogenesis of hMSCs along with high migration 
and proliferation rate were manipulated by hydrogel stiffness (Figure 14.4).74 
the same group also studied the differentiation behavior of hMSCs cultured 
in 3d hydrogels and reported an enhanced proliferation rate and neuronal 
protein marker expression in soft hydrogels containing hMSCs.75 Similarly, 
adult neural stem cells (anSCs) were cultured on the same 3d hydrogel sys-
tem and showed growth and differentiation of anSCs into central nervous 
system cell types. interestingly, they reported enhanced differentiation of 
anSCs into neuronal lineages in stiffer hydrogels as well as increased cell 
adhesion, proliferation, migration and oxidative stress resistance.76
14.2.6   Conductive, Electrical-Stimuli-Responsive 
Biomaterials
electrical signals provide communication in the nervous system at physio-
logical levels and cause charge gradients across cell membranes and nerves. 
electrical fields or stimulations alter the ion channel distribution, modulate 
voltage-influenced channels and influence nerves at the molecular level by 
affecting proliferation, migration and axonal regeneration of cells.130 Since 
damaged peripheral or spinal nerves require axonal regeneration and func-
tion for recovery, electrical stimulation has been used to enhance axonal 
growth and neuronal, astrocyte, and Schwann cell migration.130–132 in order 
to facilitate these requirements, electrical-stimuli-responsive biomaterials, 
such as conductive polymers, electrets, piezoelectric and photovoltaic mate-
rials, are considered a new class of smart materials that can stimulate cells, 
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Figure 14.4   (a) Formation of gtnehpa hydrogels by enzyme-catalyzed oxidation for 
3d and 2d cell growth and differentiation. (B) Confocal fluorescence 
microscopy of hMSCs cultured on gtnehpa hydrogels. (C) immunoflu-
orescence images of neurogenic protein markers.74 reproduced from 
Biomaterials, 31(33), Wang, l.-S., Boulaire, J., Chan, p. p. y., Chung, 
J. e., Kurisawa, M. the role of stiffness in gelatin–hydroxyphenyl-
propionic acid hydrogels formed by enzyme-mediated crosslinking 
on the differentiation of human mesenchymal stem cell, 8608–8616, 
Copyright (2010) with permission from elsevier.
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regulate specific cellular activities and influence nerve regeneration pro-
cesses upon electrical exposure.133 amongst the others, since the self-pow-
ered electrets and piezoelectric materials do not need an external power 
source to transmit an electrical stimulus, the electrical stimulus control of 
these materials is limited.134,135 On the other hand, conductive polymers, such 
as polypyrrole, polyaniline and poly(3,4-ethylenedioxythiophene), possess-
ing good electrical properties with high conductivity/weight ratios, provide 
wide external control over the electrical stimulus. Moreover, the chemical, 
electrical, physical and structural properties of conductive materials along 
with their biocompatibility and biodegradability can be tailored through the 
incorporation of biological moieties such as antibodies, enzymes and others, 
and further controlled by external or internal stimulation depending on the 
type of application.134–136 Considering the advantages of conductive materi-
als, particularly conductive polymers, and the noted positive effects of elec-
trical stimulation on nerve regeneration, these materials lend themselves as 
excellent scaffolds for neural tissue engineering purposes.
the application of electrical stimuli resulted in significant neurite exten-
sion in nerve cells. For example, pC-12 cells have been reported to show 
enhanced neurite outgrowth on ngF-doped ppy films77 and ppy–plga,78 
ppy–pdlla79 and plla–pani80 scaffolds upon electrical stimuli exposure. 
in a recent study, an inkjet-printed collagen-coated conductive ppy scaffold 
was developed with guidance tracks and showed enhanced guided neurite 
outgrowth along with the direction of the tracks upon electrical stimuli in 
pC-12 cells.81 Similar effects were also reported for the electrically stimulated 
neural cells on nanofibrous pani–pg scaffolds.137 in a different study, the 
potential of small diameter (<400 µm) fibers consisting of electrically con-
ductive polyaniline and polypropylene (pa–pp) blends was addressed for 
neural regeneration. these conductive fibers embedded in an agarose matrix 
along with primary dorsal root ganglion neurons promoted survival, adhe-
sion, neurite outgrowth and density of viable neurons resulting in neural 
network formation directly along the fibers.138 the enhanced neurite growth, 
increased neuron density and formation of neural networks upon electrical 
stimuli could be a result of the improved fibronectin adsorption onto the 
conductive polymer scaffolds along with the formed proteins and ion chan-
nels within the cell membrane.
the applied electrical stimuli can also enhance the adhesion, proliferation, 
spreading and migration of the neural cells. In situ forming biodegradable 
electroactive hydrogel gelatin-graft-polyaniline was developed by crosslink-
ing with genipin at body temperature. this in situ formed degradable elec-
troactive biomimetic hydrogel scaffold provided efficient electrical stimuli 
enhancing MSC adhesion and proliferation.82
Besides the neurite outgrowth, cellular adhesion and proliferation, 
applied electrical stimuli also promote neural differentiation. For instance, 
the 250 hz biphasic current applied through ppy/pMaS composite films was 
observed to enhance the neural differentiation in the presence of ngF.83 Sim-
ilarly, rat pheochromocytoma nerve cells, grown on fibrillar collagen-coated 
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ppy scaffolds, enhanced neural differentiation when an electrical stimulus 
was applied.84 Schwann cells, producing a myelin sheath around neuronal 
axons for the peripheral nervous system, also demonstrated good viability 
and increased ngF and BdnF secretion capacity upon application of an 
electrical stimulus of 100 mV mm−1 on chitosan–ppy composite scaffolds.139 
the enhanced adhesion, proliferation and differentiation of neural cells cul-
tured on hybrid hydrogel scaffolds obtained by chemical and electropoly-
merization of poly(3,4-ethylenedioxythiophene) (pedOt) and polyurethane 
(pU), giving rise to strong bonding of a conductive composite with an elastic 
double-network was also reported.140 the possible mechanisms of electrical 
stimulation on cell differentiation were hypothesized to be based on altering 
membrane potential through hyperpolarization and depolarization,141 mod-
ification of ion channels including density and distribution of receptors, cal-
cium channel activation,142 and up-regulation of the erK pathway.143–145 in 
addition, the activation of various signaling pathways such as MapK, pi3K 
and rOCK,146,147 and the increase in intracellular rOS generation148 were 
pointed out as other reasons of electro-trans differentiation.146,149 however, 
all of these studies used chemical- or growth-factor-based stimuli along with 
the electrical stimuli for the differentiation. therefore, the exact mechanism 
of electrical stimuli in stem cell differentiation is still unresolved.
graphene, composed of a single-atom-thick sheet of carbon atoms 
arranged in a hexagonal lattice, has been extensively used in a plethora of bio-
technological/biomedical applications and translational research including 
bioassays,150 biosensors,151,152 photothermal anticancer therapy,153 electrical 
stimulation of cells154 and drug delivery.155 recently, the potential of this 
non-cytotoxic and biocompatible and conductive material has been exploited 
as a scaffold for cell growth, differentiation, and fate conversion in tissue 
engineering and regenerative medicine.156–159 the unique physical, chemical 
and mechanical properties160,161 as well as the non-toxic, biocompatible, con-
ductive and stable nature of graphene have revealed its potential as a func-
tional scaffold material mediating cell growth, proliferation, differentiation, 
and alteration of cell fate in tissue engineering.86,154,162–168 graphene-based 
conductive substrates support electrically stimulated neuronal differentia-
tion of stem cells and provide a promising platform for neural regeneration. 
it was previously reported that a 3d porous graphene foam with electrically 
conductive properties supported neural stem cell (nSC) growth with an 
active proliferation state and enhanced nSC differentiation towards astro-
cytes and neurons through efficient electrical stimulation implicating the 
potential use of graphene for neural tissue engineering.85 in another study, 
extremely low frequency electromagnetic fields (50 hz, 1 mt) were reported 
to enhance neuronal differentiation of bone-marrow-derived human mesen-
chymal stem cells grown on a graphene-coated substrate (Figure 14.5). it was 
noted that the enhancement in neurogenesis resulted from the alteration of 
gene expression profile, up-regulation of cell adhesion through intracellular 
calcium influx and the activation of the focal adhesion kinase signaling path-
way, which is stimulated by extracellular matrix production.86
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Figure 14.5   (a) electromagnetic field (eMF)-triggered neuronal differentiation of hMSCs on the graphene-coated substrate. (B) Confocal 
images indicating the immunostaining of nestin, tUJ-1, Map2, and nCaM neuronal markers and quantification of fluores-
cent intensities in hMSCs.86 reproduced from Current Applied Physics, 15, lee, y.-J., Jang, W., im, h., Sung, J.-S. extremely low 
frequency electromagnetic fields enhance neuronal differentiation of human mesenchymal stem cells on grapheme-based 
substrates, S95–S102, Copyright (2015) with permission from elsevier.
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a novel strategy has been introduced to fabricate 3d conductive nano-
fibers through the controlled assembly of graphene oxide sheets into an 
electrospun polymer nanofiber surface providing flexibility, high electrical 
conductivity, and uniform 3d nanofiber morphology. this novel strategy and 
nanofibers enhanced electrical stimulation, accelerated cellular growth and 
primary motor neuron development.87 although the electrically conductive 
nature of graphene promotes many cellular properties, the exact differentia-
tion mechanism mediated by the graphene substrate is not fully understood. 
in addition to being used as a 3d conductive scaffold for neural differentia-
tion, graphene can also be used as a monitoring device. gold nanoparticles 
encapsulated with 3d graphene oxide were used as a non-destructive detec-
tion tool to monitor and detect neural stem cells’ (nSCs) differentiation by 
surface-enhanced raman spectroscopy (SerS). this new material was capa-
ble of promoting the double enhancement effect of graphene oxide and gold 
nanoparticles on SerS signals for undifferentiated nSCs and showed prom-
ise as a non-destructive in situ monitoring tool for the identification of the 
differentiation potential of various kinds of stem cells.88
14.3   Functional Delivery Systems for the BBB
the efficient treatment of neurodegenerative diseases affecting the central 
nervous system lies in the development of smart delivery systems that can 
cross the blood–brain barrier (BBB) and reach target tissues with their pay-
loads. the recent advances in smart and stimuli-responsive natural or syn-
thetic functional materials offer various opportunities for the development 
and design of smart vehicles able to cross the BBB.4
there are two common strategies for nanoparticles to cross the BBB: (1) 
receptor-mediated, which is achieved by ligand binding, targeting the surface 
expressed receptor on the brain capillary endothelial cells or (2) adsorptive 
mediated, in which the particle is adsorbed to the brain capillary endothelial 
cell membrane. these methods have been applied to polymer-, liposome-, 
solid-lipid-nanoparticle- and inorganic-nanoparticle-based delivery systems 
to improve the delivery of therapeutics across the BBB. in the receptor- 
mediated transcytosis, surface nanoparticles were modified by endogenous 
ligands, peptides and antibodies against the receptors including low density 
lipoprotein receptor, transferrins, leptins, epidermal growth factor, diphthe-
ria toxin, and insulin to improve transport through the BBB. Surface mod-
ifications of particles to create smart systems through a receptor-mediated 
approach for BBB penetration were summarized in our previous work.2 
despite the advantages, receptor-mediated endothelial transcytosis is lim-
ited by the quantity of receptors on the cell surface and the lack of specific-
ity. On the other hand, cell-penetrating peptides, responding to intracellular 
or extracellular stimuli, enhance the delivery of nanoparticles by adsorp-
tion-mediated transcytosis. examples include the human immunodeficiency 
virus type 1 transactivator of transcription protein, poly-arginines, and Syn-B 
vectors. the herpes simplex virus type 1 peptide (gh625) has also been shown 
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to increase the transport of polystyrene particles across the BBB. peptides 
have been used in combination with polymers. recently, a dual-functional 
drug delivery carrier was developed based on a peg–pla polymer surface 
modified by a 12-amino acid peptide, tgnyKalhphng (tgn) and a d- 
enantiomeric peptide, QShyrhiSpaQV (QSh), to target and potentially treat 
alzheimer’s disease. this dual-functional drug delivery system can diminish 
cytotoxicity to normal tissues and help to improve early diagnosis or treat-
ment of alzheimer’s disease.169,170
14.4   Clinical Potential and Applications of Smart 
Materials in Neural Tissue Engineering
Smart biomaterials have been considered as potent tools to overcome various 
clinical challenges in drug delivery, imaging, diagnostics and therapeutics.171 
however, their potential for neural tissue engineering and nerve regenera-
tion is still limited and needs further development.
a number of clinical trials employing bioengineering strategies have been 
conducted for the treatment of spinal cord injuries. in one of the studies, autol-
ogous transplantation of neural stem cells with a biocompatible matrix, rMx 
Biomatrix, for traumatic spinal cord injuries is currently in the recruitment 
phase (nCt0232666) (Federal research Clinical Center of Federal Medical & 
Biological agency 2015). in another study, a company, inVivo therapeutics, 
is testing plga poly-l-lysine-based scaffolds seeded with neural stem cells 
for the treatment of complete thoracic traumatic acute spinal cord injuries 
(nCt02138110). another functional collagen scaffold is also being tested for 
transplantation in acute spinal cord injury patients by the Chinese academy 
of Sciences (nCt02510365). a similar clinical trial based on collagen-scaf-
fold-containing mesenchymal stem cells for transplantation in spinal cord 
injuries has also been supported by the same institute (nCt02352077). there 
are also other biomaterial-based clinical trials for the treatment of periph-
eral nerve damage. Bovine-type-i-collagen-based conduits of varying caliber 
have been tested in clinical trials by neuragen to recover peripheral nerve 
gaps larger than 5 mm.172,173 rWth aachen University sponsored a clinical 
trial to test the porcine-collagen-based nerve guide, neuromaix, to create a 
conduit for axonal growth and to bridge large peripheral nerve discontinuity 
(nCt01884376). neuromaix is composed of two parts: epimaix enables the 
structural characteristics and avoids ingrowth of scar tissue while perimaix 
provides structure-mimicking endoneurial tubes providing guidance for the 
regenerating axons. the University of alberta is conducting a clinical trial 
to evaluate the possible benefit of electrical stimulation of the injured nerve 
following surgery (nCt02403661), which can further be improved by using 
electrically conductive biomaterials for peripheral nerve regeneration.
as summarized above, there is a huge potential and effort for the clinical 
applications of biomaterials to facilitate nerve regeneration. however, the 
clinical translation of smart biomaterials still needs further evaluation and 
development.
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14.5   Conclusions and Future Outlook
as summarized above, stimuli-responsive smart biomaterials serve as 
enabling technologies to overcome significant challenges associated with 
drug- and cell-based therapies addressing disorders in neural tissue engi-
neering and nerve regeneration. as described here, smart-biomateri-
al-based systems with appropriate chemistries and functionalization can be 
extremely promising for safe, effective, targeted, site-specific, and sustained 
delivery of bioactive agents and stem-cell-based therapies to treat disorders 
of the nervous system. a combination of bioactive agent delivery and stem-
cell-based therapies along with the use of smart biomaterials can signifi-
cantly impact neuroregeneration. they also offer new ways for therapeutics 
and imaging agents to traverse the BBB. Future studies will continue to 
investigate strategies using stimuli-responsive smart biomaterials to engi-
neer 3d biomimetic scaffolds with various functionalities that can be used 
to regulate stem cell fate. these smart biomaterials can significantly impact 
not only the therapies of nervous system disorders but also potentially facil-
itate diagnosis for the detection of neural disorders paving the way for trans-
lation to clinic.
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